© 2021 MJH Life Sciences and Contagion Live. All rights reserved.
© 2021 MJH Life Sciences™ and Contagion Live. All rights reserved.
April 18, 2021
With labs blinding a specific panel, a C diff diagnosis can be masked and missed.
April 14, 2021
April 12, 2021
Updated review and meta-analysis identifies the classes of antibiotics most strongly linked to healthcare facility-associated Clostridioides difficile infection.
April 10, 2021
This prognostic marker might not be an adequate reason to test for Clostridium difficile in hospitalized patients.
April 07, 2021
Oral vancomycin prophylaxis was found by a small study to prevent C diff infection in thoracic transplant patients.
April 04, 2021
The study determined that acid-base disturbances like can influence the risk of a C diff infection after cardiac surgery is performed
April 03, 2021
Clostridium difficile infection (CDI) is a leading cause of healthcare-associated infections and the clinical spectrum ranges from asymptomatic colonization to toxic megacolon and fulminant colitis.
April 02, 2021
Infection control efforts to combat hospital-onset Clostridioides difficile infection may be better spent on health care workers’ hand hygiene compliance and environmental cleaning than on visitor contact precautions, a new study suggests.
March 18, 2021
Recruitment for a phase 2 trial of a novel antibiotic against Clostridium difficile (C diff) is proceeding after phase 1 demonstrated safety and tolerability.
March 14, 2021
Rates of serious clinical complications of Clostridioides difficile infection rose as the number of recurrent infections increased, underscoring the importance of advancing new treatments to prevent recurrence of the disease, a recent study in SAGE Open Medicine found.